Input of recombinant phenotyping for the characterization of a novel acyclovir-resistance mutation identified in a patient with recurrent herpetic keratitis.


Journal

Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699

Informations de publication

Date de publication:
08 2019
Historique:
received: 13 05 2019
revised: 06 06 2019
accepted: 10 06 2019
pubmed: 15 6 2019
medline: 13 6 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

We report here a case of an immunocompetent patient suffering from recurrent epithelial herpetic keratitis associated with the emergence of antiviral resistance. Indeed, the not previously described amino acid change L340R within herpes simplex virus thymidine kinase, was shown to confer acyclovir-resistance by recombinant phenotyping using bacmid technology.

Identifiants

pubmed: 31199933
pii: S0166-3542(19)30270-0
doi: 10.1016/j.antiviral.2019.06.007
pii:
doi:

Substances chimiques

Antiviral Agents 0
Thymidine Kinase EC 2.7.1.21
Acyclovir X4HES1O11F

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-186

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Antoine Robinet-Perrin (A)

Univ. Bordeaux, CHU Bordeaux, Ophthalmology Department, CFXM, F-33000, Bordeaux, France.

Camille Tumiotto (C)

Univ. Bordeaux, CNRS-UMR 5234, CHU Bordeaux, Virology Department, F-33000, Bordeaux, France.

Thomas Cornut (T)

Univ. Bordeaux, CHU Bordeaux, Ophthalmology Department, CFXM, F-33000, Bordeaux, France.

Alexandra Santoni (A)

Univ. Bordeaux, CHU Bordeaux, Ophthalmology Department, CFXM, F-33000, Bordeaux, France.

David Touboul (D)

Univ. Bordeaux, CHU Bordeaux, Ophthalmology Department, CFXM, F-33000, Bordeaux, France.

Thibaud Goupil-Gouyette (T)

Sorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie et de Santé Publique (iPLESP), AP-HP, University Hospital Pitié-Salpêtrière - Charles-Foix, National Reference Center for Herpesviruses, Virology Department, Paris, France.

Isabelle Garrigue (I)

Univ. Bordeaux, CNRS-UMR 5234, CHU Bordeaux, Virology Department, F-33000, Bordeaux, France.

David Boutolleau (D)

Sorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie et de Santé Publique (iPLESP), AP-HP, University Hospital Pitié-Salpêtrière - Charles-Foix, National Reference Center for Herpesviruses, Virology Department, Paris, France.

Sonia Burrel (S)

Sorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie et de Santé Publique (iPLESP), AP-HP, University Hospital Pitié-Salpêtrière - Charles-Foix, National Reference Center for Herpesviruses, Virology Department, Paris, France. Electronic address: sonia.burrel@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH